A Member Board of the American Board of Medical Specialties

A- A A+


ABPLogoBlue trans


For Immediate Release


The American Board of Pathology Announces Gary W. Procop, MD, MS as Chief Executive Officer in 2022


Procop2TAMPA, Fla., (November 4, 2020) - The Trustees of the American Board of Pathology (ABPath) are pleased to announce that Gary W. Procop, MD, MS has been selected as Chief Executive Officer of the ABPath beginning January 1, 2022. In this role, Dr. Procop will oversee all aspects of the ABPath’s initial and continuing certification programs and guide the organization through its successful ongoing program improvements. Dr. Procop will succeed Dr. Rebecca L. Johnson as CEO after a transition period and upon her retirement on December 31, 2021.

Dr. Procop is currently a Medical Director in Clinical Microbiology and an Infectious Disease Pathologist at the Cleveland Clinic. He holds the Belinda Yen-Lieberman PhD and James Lieberman MD Endowed Chair in Clinical Microbiology and is the Director of Molecular Microbiology, Virology, Mycology, and Parasitology laboratories and the Vice Chair for Education. He is past Chair of the Departments of Clinical and Molecular Pathology, and past Section Head for Clinical and Molecular Microbiology. Dr. Procop, as Medical Director of Virology, is responsible for COVID-19 testing at the Cleveland Clinic and was an integral part of an interdisciplinary team resulting in Cleveland Clinic being the first hospital in Ohio to offer COVID-19 testing. The research of Dr. Procop and his team on the sensitivity and diagnostic accuracy of the five most commonly used rapid tests has been featured on national media and helped spark a closer look at the COVID-19 rapid tests on the market.

“We are very lucky to have Dr. Procop coming on as our new CEO. There are big shoes to fill after Dr. Johnson retires and he is just the right person,” states Steven H. Swerdlow, MD, ABPath President. “He is not only an internationally renowned pathologist with expertise in microbiology but has dedicated his career to dealing with pragmatic issues in the practice of pathology and with the education of our trainees and ongoing education of our diplomates. His many years of service to ABPath, the American Board of Medical Specialties (ABMS) and other pathology organizations as well as his collegial welcoming personality will stand him in good stead.”

Dr. Procop was a Trustee of the ABPath from 2007-2018 and served as President in 2016, Vice President in 2015 and Secretary in 2013-2014. His responsibilities at the ABPath included Chair of the Test Development and Advisory Committee for Microbiology, the Ethics and Professionalism Committee, and the Maintenance of Certification Committee. In August 2019, he was honored for his many contributions to the ABPath as a Life Trustee. He is board certified in Anatomic and Clinical Pathology, and Medical Microbiology.

Dr. Procop received a Bachelor of Science degree from Eastern Michigan University, followed by MD and MS degrees at Marshall University School of Medicine. He completed residency training in Anatomic and Clinical Pathology at Duke University Medical Center and fellowship training in Clinical Microbiology at the Mayo Clinic. Dr. Procop was a member and recent Chair of the ABMS Committee on Continuing Certification and serves on the ABMS Board of Directors.

About the American Board of Pathology
The mission of the American Board of Pathology, as a member of the American Board of Medical Specialties, is to serve the public and advance the profession of pathology by setting certification standards and promoting lifelong competency of pathologists.

Founded in 1936, the ABPath accomplishes this mission by establishing certification and continuing certification standards and assessing the qualifications of those seeking to obtain voluntary certification in the specialty of pathology. For more information, visit or call (813) 286-2444.

© 2015 The American Board of Pathology. All rights reserved.